Abstract
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. Reprints: Masaaki Murakami, DVM, PhD, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Japan (e-mail: [email protected]). Supported by research grants from Kakenhi; Takeda Science Foundation; Institute for Fermentation, Osaka; Mitsubishi Foundation; Tokyo Medical Research Foundation; Uehara Memorial Foundation; Akiyama Life Science Foundation; Chugai Pharmaceutical Co Ltd; Takeda Pharmaceutical Co Ltd; Shionogi Co Ltd; and Sumitomo Dainippon Pharmaceutical Co Ltd. Ono Pharmaceutical Co Ltd, Gene Techno Science, Timelapse Vision/Sanofi, AMED-SICP, and JAXA-JSF to M. Murakami. M. Murakami has received consultation fees from Takeda Pharmaceutical Co Ltd and funding for research from Chugai Pharmaceutical Co Ltd, Takeda Pharmaceutical Co Ltd, Shionogi Co Ltd, Sumitomo Dainippon Pharmaceutical Co Ltd, Ono Pharmaceutical Co Ltd, Gene Techno Science, and Timelapse Vision/Sanofi.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.